Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 29;8(12):1258.
doi: 10.3390/jof8121258.

Epidemiologic Aspects of Mycetoma in Africa

Affiliations
Review

Epidemiologic Aspects of Mycetoma in Africa

Michel Develoux. J Fungi (Basel). .

Abstract

Mycetoma is a chronic, disabling infection caused by fungi or actinomycetes that affects the disadvantaged rural populations of arid tropical regions. The identification of etiological agents is long, difficult, and often imprecise or unsuccessful. Recently developed molecular methods can be used to identify causal agents at the species level. However, diagnosis can only be implemented in specialized laboratories. For these reasons, the distribution of causal agents in endemic African countries remains approximate. It is known that the pathogenic organisms of mycetoma are present in the environment, introduced as a result of injuries or trauma. There are still unknowns concerning the natural habitats of agents and the mode of infection. A potential association between mycetoma and acacia was uncovered in Sudan, allowing the elaboration of a risk map of the country. A new hypothesis for the mode of contamination involves the intervention of an intermediate host. The first surveys in Sudanese endemic villages gave a higher prevalence than the previous estimates, indicating that the prevalence of mycetoma in endemic African countries has previously been underestimated.

Keywords: Africa; epidemiology; etiological agents; geographical distribution; mode of infection; mycetoma; prevalence.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Black-grain eumycetoma in a Senegalese patient.
Figure 2
Figure 2
Thorn in a Falcimosporma sp. grain (R. Camain, Dakar).
Figure 3
Figure 3
Prevalence of mycetoma (DNDi 2019 adapted from van de Sande WWJ [4]).

References

    1. Emery D., Denning D.W. The global distribution of actinomycetoma and eumycetoma. PLoS Negl. Trop. Dis. 2020;14:e0008397. doi: 10.1371/journal.pntd.0008397. - DOI - PMC - PubMed
    1. Siddig E.E., Ahmed A., Ali Y., Bakhert S.M., Mohamed N.S., Ahmed E.S., Fahal A.H. Eumycetoma medical treatment: Past, current practice, latest advances and perspectives. Microbiol. Res. 2021;12:899–906. doi: 10.3390/microbiolres12040066. - DOI
    1. van de Sande W., Fahal A., Ahmed S.A., Serrano J.A., Bonifaz A., Zijstra E. Closing the mycetoma knowledge gap. Med. Mycol. 2018;56:S153–S164. doi: 10.1093/mmy/myx061. - DOI - PubMed
    1. van de Sande W.W.J. Global burden of human mycetoma: A systematic review and meta-analysis. PLoS Negl. Trop. Dis. 2013;7:e2550. doi: 10.1371/journal.pntd.0002550. - DOI - PMC - PubMed
    1. Desnos-Ollivier M., Bretagne S., Dromer F., Lortholary O. Molecular identification of black- grain mycetoma agents. J. Clin. Microbiol. 2006;44:3117–3523. doi: 10.1128/JCM.00862-06. - DOI - PMC - PubMed

LinkOut - more resources